2021 Distinguished Faculty Award Priya S. Kishnani, MD, HS'91-'95
Priya Kishnani, MD, HS'91-'95, is the Chen Family Distinguished Professor of Pediatrics, chief of the Division of Medical Genetics, a professor in the Department of Molecular Genetics and Microbiology, core faculty member of the Duke Innovation and Entrepreneurship Initiatives, and member of the Duke Clinical Research Institute.
Understanding the influence of spiritual beliefs on epilepsy care
In Uganda, a person who suffers the repeated seizures associated with epilepsy is most likely to seek help first from a traditional or spiritual healer.
Duke-led team identifies new coronavirus threat to humans
Researchers have discovered a new coronavirus, found in a child with pneumonia in Malaysia in 2018, that appears to have jumped from dog to human.
Dr. Priya Kishnani Works to Improve the Lives of Children with Genetic Diseases
Dr. Priya Kishnani grew up in a family of physicians, including her mother, a pediatrician, in Mumbai (then Bombay), India.
Harnessing the Body’s Ability to Heal Itself
What if we could disable the defense mechanisms that enable cancer cells to evade treatment, or even control their genes to prevent them from developing into tumors in the first place?
SoM Researchers Named Burroughs Wellcome Fund 2021 Investigators in the Pathogenesis of Infectious Disease
Three Duke University School of Medicine researchers were named Burroughs Wellcome Fund 2021 Investigators in the highly competitive
Into the Deep End
In January of 2020, Loren Robinson, MD’09, and the rest of the leadership at CHRISTUS St. Michael Health System, a 312-bed hospital in Texarkana, Texas, gathered to conduct an annual tabletop exercise in crisis management, mandated as part of the hospital’s regulatory requirements.
An Absolute Duty
When Thom Mayer, MD’77, enrolled at Hanover College in Indiana on a football scholarship, he had no career aspirations in medicine. In fact, he had no career aspirations at all, beyond riding football as far as it could take him.
Newly Identified Antibody Can Be Targeted by HIV Vaccines
A newly identified group of antibodies that binds to a coating of sugars on the outer shell of HIV is effective in neutralizing the virus and points to a novel vaccine approach that could also pote